C4 THERAPEUTICS INC

Ticker: CCCC CUSIP: 12529R107 Class: Common Stock

Bain Capital Life Sciences Investors, LLC's Holding History (CIK: 0001703031)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 7,171,910 Value ($000) $13,698 Avg Close $2.37 Range $1.90 - $2.84
Q3 2025
Shares 1,111,910 Value ($000) $2,468 Avg Close $2.40 Range $1.40 - $3.65
Q2 2025
Shares 1,111,910 Value ($000) $1,590 Avg Close $1.45 Range $1.08 - $1.79
Q1 2025
Shares 1,111,910 Value ($000) $1,779 Avg Close $2.98 Range $1.58 - $4.26
Q4 2024
Shares 1,111,910 Value ($000) $4,003 Avg Close $4.97 Range $3.43 - $7.14
Q3 2024
Shares 1,111,910 Value ($000) $6,338 Avg Close $6.02 Range $4.36 - $7.66
Q2 2024
Shares 1,111,910 Value ($000) $5,137 Avg Close $5.96 Range $3.91 - $8.29
Q1 2024
Shares 1,142,210 Value ($000) $9,332 Avg Close $7.75 Range $5.00 - $11.88
Q4 2023
Shares 1,642,210 Value ($000) $9,278 Avg Close $2.28 Range $1.06 - $8.37
Q3 2023
Shares 1,642,210 Value ($000) $3,055 Avg Close $3.05 Range $1.72 - $3.95
Q2 2023
Shares 1,642,210 Value ($000) $4,516 Avg Close $3.21 Range $2.60 - $3.90
Q1 2023
Shares 1,642,210 Value ($000) $5 Avg Close $5.89 Range $3.00 - $9.41
Q4 2022
Shares 1,642,210 Value ($000) $10 Avg Close $8.29 Range $5.34 - $10.42
Q3 2022
Shares 1,642,210 Value ($000) $14,402 Avg Close $10.38 Range $7.35 - $13.23
Q2 2022
Shares 1,642,210 Value ($000) $12,382 Avg Close $8.80 Range $4.84 - $26.80
Q1 2022
Shares 1,642,210 Value ($000) $39,840 Avg Close $24.28 Range $19.81 - $33.76
Q4 2021
Shares 1,642,210 Value ($000) $52,879 Avg Close $39.55 Range $27.84 - $48.75
Q3 2021
Shares 1,642,209 Value ($000) $73,374 Avg Close $42.82 Range $34.47 - $51.21
Q2 2021
Shares 1,642,209 Value ($000) $62,141 Avg Close $35.81 Range $29.55 - $43.50
Q1 2021
Shares 1,642,209 Value ($000) $60,745 Avg Close $39.78 Range $30.55 - $48.98
Q4 2020
Shares 1,642,209 Value ($000) $54,406 Avg Close $29.00 Range $22.40 - $37.80